Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus

Rheumatology (Oxford). 2013 May;52(5):951-2. doi: 10.1093/rheumatology/ket004. Epub 2013 Feb 18.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal, Murine-Derived / blood*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antigens, CD19 / drug effects
  • Antigens, CD19 / immunology*
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD19
  • Rituximab